Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RP
1726
DELISTED
RealPage, Inc.
RP
| $4.41M | ﹤0.01% |
+67,894
| New | +$4.28M |
|
1727
Ichor Holdings
ICHR
$2.66B
| $4.41M | ﹤0.01% |
166,000
+49,300
| +42% | +$1.13M |
|
1728
Canadian National Railway
CNI
$76.7B
| $4.41M | ﹤0.01% |
49,800
-73,700
| -60% | -$6.13M |
|
1729
BJ's Restaurants
BJRI
$1.45B
| $4.39M | ﹤0.01% |
209,629
+47,100
| +29% | +$933K |
|
1730
Terreno Realty
TRNO
$7.43B
| $4.38M | ﹤0.01% |
83,300
-78,053
| -48% | -$4.05M |
|
1731
Hingham Institution for Saving
HIFS
$680M
| $4.37M | ﹤0.01% |
26,019
+300
| +1% | +$46.6K |
|
|
PRFT
1732
DELISTED
Perficient Inc
PRFT
| $4.36M | ﹤0.01% |
121,893
+8,900
| +8% | +$295K |
|
|
CSTR
1733
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $4.36M | ﹤0.01% |
363,199
-9,700
| -3% | -$105K |
|
1734
Saga Communications
SGA
$62.1M
| $4.35M | ﹤0.01% |
169,807
-5,407
| -3% | -$142K |
|
|
XEC
1735
DELISTED
CIMAREX ENERGY CO
XEC
| $4.34M | ﹤0.01% |
157,730
-284,400
| -64% | -$7.05M |
|
1736
Northwest Natural Holdings
NWN
$2.14B
| $4.33M | ﹤0.01% |
77,700
-237,857
| -75% | -$14.5M |
|
1737
GATX Corp
GATX
$6.38B
| $4.31M | ﹤0.01% |
+70,700
| New | +$4.25M |
|
1738
Marchex
MCHX
$82M
| $4.31M | ﹤0.01% |
2,727,211
-38,749
| -1% | -$58.6K |
|
|
ARAV
1739
DELISTED
Aravive, Inc. Common Stock
ARAV
| $4.3M | ﹤0.01% |
369,875
-171,406
| -32% | -$2.03M |
|
|
CETV
1740
DELISTED
Central European Media Enterprises Ltd
CETV
| $4.3M | ﹤0.01% |
1,215,297
+299,279
| +33% | +$1.11M |
|
|
BBT
1741
Beacon Financial Corp
BBT
$2.69B
| $4.28M | ﹤0.01% |
388,579
-289,300
| -43% | -$3.72M |
|
1742
Flexsteel Industries
FLXS
$301M
| $4.27M | ﹤0.01% |
337,793
+77,600
| +30% | +$777K |
|
1743
Sally Beauty Holdings
SBH
$1.54B
| $4.25M | ﹤0.01% |
339,318
-205,249
| -38% | -$2.25M |
|
|
RADA
1744
DELISTED
Rada Electronic Industries Ltd
RADA
| $4.25M | ﹤0.01% |
649,771
-9,065
| -1% | -$44.8K |
|
|
CDTX
1745
DELISTED
Cidara Therapeutics
CDTX
| $4.24M | ﹤0.01% |
57,477
+10,697
| +23% | +$693K |
|
|
AERI
1746
DELISTED
Aerie Pharmaceuticals
AERI
| $4.22M | ﹤0.01% |
+286,000
| New | +$4.23M |
|
|
CTG
1747
DELISTED
Computer Task Group, Inc.
CTG
| $4.22M | ﹤0.01% |
1,047,197
-2,068
| -0.2% | -$8.46K |
|
1748
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.58B
| $4.21M | ﹤0.01% |
176,600
+156,200
| +766% | +$3.35M |
|
1749
Vishay Intertechnology
VSH
$5.38B
| $4.21M | ﹤0.01% |
275,925
+79,237
| +40% | +$1.23M |
|
|
VIVS
1750
VivoSim Labs
VIVS
$1.13M
| $4.21M | ﹤0.01% |
31,893
+1,504
| +5% | +$183K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.